These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 12620640)
41. Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II. Ruggiero P; Bossù P; Macchia G; Del Grosso E; Sabbatini V; Bertini R; Colagrande A; Bizzarri C; Maurizi G; Di Cioccio V; D'Andrea G; Di Giulio A; Frigerio F; Grifantini R; Grandi G; Tagliabue A; Boraschi D J Immunol; 1997 Apr; 158(8):3881-7. PubMed ID: 9103457 [TBL] [Abstract][Full Text] [Related]
42. Molecular and functional characterization of an IL-1β receptor antagonist in grass carp (Ctenopharyngodon idella). Yao F; Yang X; Wang X; Wei H; Zhang A; Zhou H Dev Comp Immunol; 2015 Apr; 49(2):207-16. PubMed ID: 25475961 [TBL] [Abstract][Full Text] [Related]
43. Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor. Loscher CE; Mills KH; Lynch MA J Neuroimmunol; 2003 Apr; 137(1-2):117-24. PubMed ID: 12667655 [TBL] [Abstract][Full Text] [Related]
44. Aspirin-induced increases in soluble IL-1 receptor type II concentrations in vitro and in vivo. Daun JM; Ball RW; Burger HR; Cannon JG J Leukoc Biol; 1999 Jun; 65(6):863-6. PubMed ID: 10380911 [TBL] [Abstract][Full Text] [Related]
45. Impaired suppression of feeding by the gut hormone xenin in type I interleukin-1 receptor-deficient mice. Kim ER; Xu Y; Mizuno TM Behav Brain Res; 2014 Mar; 261():60-4. PubMed ID: 24333379 [TBL] [Abstract][Full Text] [Related]
46. Structure-function relationship in the IL-1 family. Boraschi D; Bossu P; Macchia G; Ruggiero P; Tagliabue A Front Biosci; 1996 Oct; 1():d270-308. PubMed ID: 9159234 [TBL] [Abstract][Full Text] [Related]
47. Lessons from interleukin-deficient mice: the interleukin-1 system. Fantuzzi G Acta Physiol Scand; 2001 Sep; 173(1):5-9. PubMed ID: 11678721 [TBL] [Abstract][Full Text] [Related]
48. Expression of IL-1beta, IL-1 receptor type I and IL-1 receptor antagonist in human aortic smooth muscle cells: effects of all-trans-retinoic acid. Wågsater D; Jatta K; Ocaya P; Dimberg J; Sirsjo A J Vasc Res; 2006; 43(4):377-82. PubMed ID: 16804330 [TBL] [Abstract][Full Text] [Related]
49. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835 [TBL] [Abstract][Full Text] [Related]
50. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Burns K; Clatworthy J; Martin L; Martinon F; Plumpton C; Maschera B; Lewis A; Ray K; Tschopp J; Volpe F Nat Cell Biol; 2000 Jun; 2(6):346-51. PubMed ID: 10854325 [TBL] [Abstract][Full Text] [Related]
51. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis. Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477 [TBL] [Abstract][Full Text] [Related]
53. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II. Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824 [TBL] [Abstract][Full Text] [Related]
54. Basal and IL-1beta-stimulated cytokine and neuropeptide mRNA expression in brain regions of young and old Long-Evans rats. Gayle D; Ilyin SE; Romanovitch AE; Peloso E; Satinoff E; Plata-Salamán CR Brain Res Mol Brain Res; 1999 Jun; 70(1):92-100. PubMed ID: 10381547 [TBL] [Abstract][Full Text] [Related]
55. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. Lang D; Knop J; Wesche H; Raffetseder U; Kurrle R; Boraschi D; Martin MU J Immunol; 1998 Dec; 161(12):6871-7. PubMed ID: 9862719 [TBL] [Abstract][Full Text] [Related]
56. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains. Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472 [TBL] [Abstract][Full Text] [Related]
57. Induction of intracellular interleukin-1 beta signals via type II interleukin-1 receptor in human gingival fibroblasts. Chou HH; Takashiba S; Maeda H; Naruishi K; Nishimura F; Arai H; Lu H; Murayama Y J Dent Res; 2000 Sep; 79(9):1683-8. PubMed ID: 11023264 [TBL] [Abstract][Full Text] [Related]
58. Causal links between brain cytokines and experimental febrile convulsions in the rat. Heida JG; Pittman QJ Epilepsia; 2005 Dec; 46(12):1906-13. PubMed ID: 16393156 [TBL] [Abstract][Full Text] [Related]
59. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Somm E; Cettour-Rose P; Asensio C; Charollais A; Klein M; Theander-Carrillo C; Juge-Aubry CE; Dayer JM; Nicklin MJ; Meda P; Rohner-Jeanrenaud F; Meier CA Diabetologia; 2006 Feb; 49(2):387-93. PubMed ID: 16385385 [TBL] [Abstract][Full Text] [Related]
60. Interleukin-1 beta up-regulates tissue inhibitor of matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells. Zhang YP; Yao XX; Zhao X World J Gastroenterol; 2006 Mar; 12(9):1392-6. PubMed ID: 16552807 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]